Zhanna Kalikhman
Internal Medicine · Elkridge, MDNPI 1679539829
Payments from drug & device makers
Across 102 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$300
- AbbVie$286
- AstraZeneca$176
- Novo Nordisk$129
- Takeda Pharmaceuticals U.S.A., Inc.$86
- Otsuka America Pharmaceutical, Inc.$73
- plus $544 from 16 others
What the payments were for
- Food & beverage$1,54597%
- Education$503%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 18 | $300 |
| AbbVie(2 entities) | 16 | $286 |
| AstraZeneca | 13 | $176 |
| Novo Nordisk | 8 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $86 |
| Otsuka America Pharmaceutical, Inc. | 5 | $73 |
| Teva Pharmaceuticals USA, Inc. | 4 | $59 |
| Adlon Therapeutics L.p. | 3 | $58 |
| Sunovion Pharmaceuticals Inc. | 4 | $56 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $50 |
| Jazz Pharmaceuticals Inc. | 3 | $48 |
| Amarin Pharma, Inc. | 3 | $47 |
| Merz North America, Inc. | 3 | $46 |
| Novartis | 3 | $45 |
| Boehringer Ingelheim | 2 | $27 |
| Merck | 2 | $26 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| GSK | 1 | $16 |
| Radius Health, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Lundbeck LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$110
How this compares
$1,594 in reported general payments places this provider in the 75th percentile of 2,979 internal medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 76 | $104,276 |
| JardianceEmpagliflozin | 35 | $48,668 |
| NamzaricMemantine Hcl/Donepezil Hcl | 11 | $6,490 |
| Rosuvastatin Calcium | 111 | $2,815 |
| Propranolol Hcl ErPropranolol Hcl | 15 | $1,326 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 11 | $1,284 |
| Duloxetine Hcl | 59 | $1,252 |
| Famotidine | 50 | $1,246 |
| SynthroidLevothyroxine Sodium | 18 | $975 |
| Atorvastatin Calcium | 86 | $941 |
| Escitalopram Oxalate | 32 | $837 |
| Gabapentin | 53 | $832 |
| Metformin Hcl ErMetformin Hcl | 66 | $823 |
| Quetiapine Fumarate | 20 | $723 |
| Olmesartan Medoxomil | 19 | $690 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $300 | $104,27676 claims |
| Boehringer IngelheimJardiance | $27 | $48,66835 claims |
| AbbVieNamzaric, Synthroid | $286 | $7,46529 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Elkridge
- Steven GellerElkridge$15.1M
- Shishir KhetanRockville$52.1M
- Mary HowellHagerstown$6.2M
- Kristen MarroneBaltimore$5.6M
- Jonathan CohenRockville$5M
- Andrea ApoloBethesda$4.8M
- Peta-Gay Jackson BoothBaltimore$3.6M
- Rahul PatelRockville$2.8M
- Mark YarchoanBaltimore$2.4M
- Marianne MannHighland$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.